Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex

Objective: We aimed to analyse the effects of age and sex on performance and cost for patients with chronic peripheral neuropathic pain (PNP) who have started treatment with brand name gabapentin versus generic gabapentin (EFG). Methods: We conducted a retrospective multicentre study using electroni...

Full description

Bibliographic Details
Main Authors: R. Navarro-Artieda, J. Rejas-Gutiérrez, M. Pérez-Paramo, A. Sicras-Mainar
Format: Article
Language:English
Published: Elsevier España 2018-04-01
Series:Neurología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580818300105